These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24820867)

  • 41. Rationale and methods of the IDOMENEO health outcomes of the peripheral arterial disease revascularisation study in the GermanVasc registry.
    Debus ES; Kriston L; Schwaneberg T; Hischke S; Rieß HC; Härter M; Marschall U; Federrath H; Behrendt CA
    Vasa; 2018 Oct; 47(6):499-505. PubMed ID: 30113269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discharge Prescription Patterns for Antiplatelet Therapy Following Lower Extremity Peripheral Vascular Intervention.
    Singh N; Ding L; Magee GA; Shavelle DM; Kashyap VS; Garg PK
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e008791. PubMed ID: 32791948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invited commentary.
    Belkin M
    J Vasc Surg; 2016 Apr; 63(4):965. PubMed ID: 27016855
    [No Abstract]   [Full Text] [Related]  

  • 44. Quality of life among lower extremity peripheral arterial disease patients who have undergone endovascular or surgical revascularization: a case-control study.
    Remes L; Isoaho R; Vahlberg T; Viitanen M; Rautava P
    Eur J Vasc Endovasc Surg; 2010 Nov; 40(5):618-25. PubMed ID: 20418121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is Open Vascular Surgery or Endovascular Surgery the Better Option for Lower Extremity Arterial Occlusive Disease?
    Siracuse JJ; Farber A
    Adv Surg; 2017 Sep; 51(1):207-217. PubMed ID: 28797341
    [No Abstract]   [Full Text] [Related]  

  • 46. A MultiCenter Pilot Randomized Controlled Trial of Remote Ischemic Preconditioning in Major Vascular Surgery.
    Healy DA; Boyle E; McCartan D; Bourke M; Medani M; Ferguson J; Yagoub H; Bashar K; O'Donnell M; Newell J; Canning C; McMonagle M; Dowdall J; Cross S; O'Daly S; Manning B; Fulton G; Kavanagh EG; Burke P; Grace PA; Moloney MC; Walsh SR;
    Vasc Endovascular Surg; 2015 Nov; 49(8):220-7. PubMed ID: 26574485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regarding "peripheral arterial interventions: trends in market share and outcomes by specialty, 1998-2005".
    Sacks D
    J Vasc Surg; 2010 Jul; 52(1):258-9; author reply 259. PubMed ID: 20620777
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of endovascular therapy for peripheral arterial lesions: an analysis of the National Trauma Data Bank from 2007 to 2009.
    Worni M; Scarborough JE; Gandhi M; Pietrobon R; Shortell CK
    Ann Vasc Surg; 2013 Apr; 27(3):299-305. PubMed ID: 22968090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of risk factors for length of stay and readmission following lower extremity bypass surgery.
    Damrauer SM; Gaffey AC; DeBord Smith A; Fairman RM; Nguyen LL
    J Vasc Surg; 2015 Nov; 62(5):1192-200.e1. PubMed ID: 26384761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of incidental renal artery stenosis on long-term mortality in patients with peripheral arterial disease undergoing vascular procedure.
    Mui KW; Zeebregts CJ; van den Hout H; van Baal JG; Navis G; Jan-Woittiez A
    J Vasc Surg; 2011 Sep; 54(3):785-90. PubMed ID: 21798691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex Differences in Outcomes Following Endovascular Treatment for Symptomatic Peripheral Artery Disease: An Analysis From the K- VIS ELLA Registry.
    Choi KH; Park TK; Kim J; Ko YG; Yu CW; Yoon CH; Lee JH; Min PK; Koh YS; Chae IH; Choi D; Choi SH;
    J Am Heart Assoc; 2019 Jan; 8(2):e010849. PubMed ID: 30663486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Invited commentary.
    Patterson RB
    J Vasc Surg; 2010 Jan; 51(1):78-9. PubMed ID: 20117495
    [No Abstract]   [Full Text] [Related]  

  • 53. Predictive Model for Mortality Risk Including the Wound, Ischemia, Foot Infection Classification in Patients Undergoing Revascularization for Critical Limb Ischemia.
    Azuma N; Takahara M; Kodama A; Soga Y; Terashi H; Tazaki J; Yamaoka T; Koya A; Iida O
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008015. PubMed ID: 31771341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defining the 90-day cost structure of lower extremity revascularization for alternative payment model assessment.
    Duwayri YM; Aiello FA; Tracci MC; Nedza S; Ryan PC; Adams JG; Shutze WP; Lum YW; Woo K
    J Vasc Surg; 2021 Feb; 73(2):662-673.e3. PubMed ID: 32652115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The "patient preferences gap" and the "standard gamble".
    Hirsch AT
    J Vasc Interv Radiol; 2011 Dec; 22(12):1662-4. PubMed ID: 22115579
    [No Abstract]   [Full Text] [Related]  

  • 56. If you build it…Why won't they come?
    McLafferty RB
    J Vasc Surg; 2015 Nov; 62(5):1348-52. PubMed ID: 26404180
    [No Abstract]   [Full Text] [Related]  

  • 57. Interventional cardiology: Sex-specific outcomes in PVI for PAD.
    Geach T
    Nat Rev Cardiol; 2014 Jul; 11(7):373. PubMed ID: 24820867
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of sex on morbidity and mortality rates after lower extremity interventions for peripheral arterial disease: observations from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Jackson EA; Munir K; Schreiber T; Rubin JR; Cuff R; Gallagher KA; Henke PK; Gurm HS; Grossman PM
    J Am Coll Cardiol; 2014 Jun; 63(23):2525-2530. PubMed ID: 24747101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss to follow-up 1 year after lower extremity peripheral vascular intervention is associated with worse survival.
    Wang GJ; Judelson DR; Goodney PP; Bertges DJ
    Vasc Med; 2019 Aug; 24(4):332-338. PubMed ID: 31195896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.
    Liang P; Li C; O'Donnell TFX; Lo RC; Soden PA; Swerdlow NJ; Schermerhorn ML
    J Vasc Surg; 2019 Feb; 69(2):482-489. PubMed ID: 30301689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.